TipRanks
Go Ultimate55% OFF

Attendo AB (0RCY) AI Stock Analysis

GB:0RCY

Attendo AB

(LSE:0RCY)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Revenue and earnings recoveryStrong TTM revenue growth, following a multi-year increase, indicates expanding activity across Attendo’s care-services operations. The concurrent recovery in operating and net margins suggests improved earnings power, providing a stronger base for sustained performance over the next several quarters.
Negative Factors
High financial leverageAttendo’s substantial debt relative to equity reduces financial flexibility and leaves less capacity to absorb weaker operating conditions. Elevated leverage can also constrain investment and capital allocation, making durable earnings improvement and consistent cash generation especially important to maintaining stability.

Attendo AB (0RCY) vs. iShares MSCI United Kingdom ETF (EWC)

-10%0%10%20%30%40%50%60%70%GB:0RCY+46.64%EWC+21.27%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
SEK 16.60B
Dividend Yield
0.77%
Average Volume (3M)
15.99K
Price to Earnings (P/E)
17.5
Beta (1Y)
0.87
Revenue Growth
-1.07%
EPS Growth
81.76%
Country
UK
Employees
33,000
Sector
General
Sector Strength
55
Industry
Medical - Care Facilities

Attendo AB Business Overview & Revenue Model

Company Description

Founded in 1985 and based in Danderyd, Sweden, Attendo AB (publ) is a prominent provider of publicly financed care services across the Nordic countries, including Sweden, Finland, Norway, and Denmark. The company's extensive service portfolio address...

Attendo AB Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

GB:0RCY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
SE:CARESE:CARE71OutperformSEK 700.59M14.12――12.86%18.01%
SE:MCOV.BSE:MCOV.B69NeutralSEK 43.08B45.87―0.78%5.73%90.34%
SE:AMBEASE:AMBEA68NeutralSEK 15.41B19.3815.11%1.43%13.33%28.61%
SE:ASKERSE:ASKER58NeutralSEK 27.32B40.00―0.55%――
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

-20%0%20%40%60%GB:0RCYSE:MCOV.BSE:AMBEASE:CARESE:ASKERDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
GB:0RCY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
GB:0RCYAttendo AB116.8037.2046.73%
SE:MCOV.BMedicover283.5032.6213.00%
SE:AMBEAAmbea AB185.1061.0849.25%
SE:CARECareium AB28.802.509.51%
SE:ASKERAsker Healthcare Group AB71.20-16.88-19.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.